Global Circulating Tumor Cell(CTC)Detection Market
授權報價
| Single User License | $3,480 USD |
| Multi User License | $5,220 USD |
| Corporate Users License | $6,960 USD |
完整報告名稱與涵蓋範圍
Global Circulating Tumor Cell(CTC)Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032
報告摘要
According to our (Global Info Research) latest study, the global Circulating Tumor Cell(CTC)Detection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The free tumor cell (CTC) test is a method used to detect and analyze tumor cells circulating in the blood. CTCs are cancer cells that fall off from the primary tumor and enter the blood circulation. By detecting these cells, important information about cancer progression, metastasis risk, and treatment efficacy can be provided. CTC detection is a non-invasive liquid biopsy technology that can monitor the development of cancer in real time and help doctors optimize personalized treatment plans. It is particularly suitable for early diagnosis of cancer, prediction of recurrence, and efficacy evaluation.
This report is a detailed and comprehensive analysis for global Circulating Tumor Cell(CTC)Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Circulating Tumor Cell(CTC)Detection market size and forecasts, in consumption value ($ Million), 2021-2032
Global Circulating Tumor Cell(CTC)Detection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Circulating Tumor Cell(CTC)Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Circulating Tumor Cell(CTC)Detection market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Circulating Tumor Cell(CTC)Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Circulating Tumor Cell(CTC)Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Circulating Tumor Cell(CTC)Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Epithelial Cell Phenotype
Mesenchymal Cell Phenotype
Mixed Epithelial-Mesenchymal Phenotype
Market segment by Application
Cancer Diagnosis
Tumor Dynamic Assessment
Tumor Recurrence Monitoring
Market segment by players, this report covers
Rarecyte
ANGLE plc
Biocept Inc.
Bio-Rad Laboratories Inc.
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Circulating Tumor Cell(CTC)Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Circulating Tumor Cell(CTC)Detection, with revenue, gross margin, and global market share of Circulating Tumor Cell(CTC)Detection from 2021 to 2026.
Chapter 3, the Circulating Tumor Cell(CTC)Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Circulating Tumor Cell(CTC)Detection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Circulating Tumor Cell(CTC)Detection.
Chapter 13, to describe Circulating Tumor Cell(CTC)Detection research findings and conclusion.
目錄 Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Circulating Tumor Cell(CTC)Detection by Type
1.3.1 Overview: Global Circulating Tumor Cell(CTC)Detection Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Type in 2025
1.3.3 Epithelial Cell Phenotype
1.3.4 Mesenchymal Cell Phenotype
1.3.5 Mixed Epithelial-Mesenchymal Phenotype
1.4 Global Circulating Tumor Cell(CTC)Detection Market by Application
1.4.1 Overview: Global Circulating Tumor Cell(CTC)Detection Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Cancer Diagnosis
1.4.3 Tumor Dynamic Assessment
1.4.4 Tumor Recurrence Monitoring
1.5 Global Circulating Tumor Cell(CTC)Detection Market Size & Forecast
1.6 Global Circulating Tumor Cell(CTC)Detection Market Size and Forecast by Region
1.6.1 Global Circulating Tumor Cell(CTC)Detection Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Circulating Tumor Cell(CTC)Detection Market Size by Region, (2021-2032)
1.6.3 North America Circulating Tumor Cell(CTC)Detection Market Size and Prospect (2021-2032)
1.6.4 Europe Circulating Tumor Cell(CTC)Detection Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size and Prospect (2021-2032)
1.6.6 South America Circulating Tumor Cell(CTC)Detection Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size and Prospect (2021-2032)
2 Company Profiles
2.1 Rarecyte
2.1.1 Rarecyte Details
2.1.2 Rarecyte Major Business
2.1.3 Rarecyte Circulating Tumor Cell(CTC)Detection Product and Solutions
2.1.4 Rarecyte Circulating Tumor Cell(CTC)Detection Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Rarecyte Recent Developments and Future Plans
2.2 ANGLE plc
2.2.1 ANGLE plc Details
2.2.2 ANGLE plc Major Business
2.2.3 ANGLE plc Circulating Tumor Cell(CTC)Detection Product and Solutions
2.2.4 ANGLE plc Circulating Tumor Cell(CTC)Detection Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 ANGLE plc Recent Developments and Future Plans
2.3 Biocept Inc.
2.3.1 Biocept Inc. Details
2.3.2 Biocept Inc. Major Business
2.3.3 Biocept Inc. Circulating Tumor Cell(CTC)Detection Product and Solutions
2.3.4 Biocept Inc. Circulating Tumor Cell(CTC)Detection Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Biocept Inc. Recent Developments and Future Plans
2.4 Bio-Rad Laboratories Inc.
2.4.1 Bio-Rad Laboratories Inc. Details
2.4.2 Bio-Rad Laboratories Inc. Major Business
2.4.3 Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Product and Solutions
2.4.4 Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bio-Rad Laboratories Inc. Recent Developments and Future Plans
2.5 Fluxion Biosciences Inc.
2.5.1 Fluxion Biosciences Inc. Details
2.5.2 Fluxion Biosciences Inc. Major Business
2.5.3 Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Product and Solutions
2.5.4 Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Fluxion Biosciences Inc. Recent Developments and Future Plans
2.6 F. Hoffmann-La Roche AG
2.6.1 F. Hoffmann-La Roche AG Details
2.6.2 F. Hoffmann-La Roche AG Major Business
2.6.3 F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Product and Solutions
2.6.4 F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
2.7 Sysmex Europe SE
2.7.1 Sysmex Europe SE Details
2.7.2 Sysmex Europe SE Major Business
2.7.3 Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Product and Solutions
2.7.4 Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sysmex Europe SE Recent Developments and Future Plans
2.8 Qiagen
2.8.1 Qiagen Details
2.8.2 Qiagen Major Business
2.8.3 Qiagen Circulating Tumor Cell(CTC)Detection Product and Solutions
2.8.4 Qiagen Circulating Tumor Cell(CTC)Detection Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Qiagen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Circulating Tumor Cell(CTC)Detection Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Circulating Tumor Cell(CTC)Detection by Company Revenue
3.2.2 Top 3 Circulating Tumor Cell(CTC)Detection Players Market Share in 2025
3.2.3 Top 6 Circulating Tumor Cell(CTC)Detection Players Market Share in 2025
3.3 Circulating Tumor Cell(CTC)Detection Market: Overall Company Footprint Analysis
3.3.1 Circulating Tumor Cell(CTC)Detection Market: Region Footprint
3.3.2 Circulating Tumor Cell(CTC)Detection Market: Company Product Type Footprint
3.3.3 Circulating Tumor Cell(CTC)Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Circulating Tumor Cell(CTC)Detection Consumption Value and Market Share by Type (2021-2026)
4.2 Global Circulating Tumor Cell(CTC)Detection Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
5.1 Global Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Application (2021-2026)
5.2 Global Circulating Tumor Cell(CTC)Detection Market Forecast by Application (2027-2032)
6 North America
6.1 North America Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2032)
6.2 North America Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2032)
6.3 North America Circulating Tumor Cell(CTC)Detection Market Size by Country
6.3.1 North America Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2021-2032)
6.3.2 United States Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
6.3.3 Canada Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
6.3.4 Mexico Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
7 Europe
7.1 Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2032)
7.2 Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2032)
7.3 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country
7.3.1 Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2021-2032)
7.3.2 Germany Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
7.3.3 France Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
7.3.5 Russia Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
7.3.6 Italy Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region
8.3.1 Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Region (2021-2032)
8.3.2 China Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
8.3.3 Japan Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
8.3.4 South Korea Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
8.3.5 India Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
8.3.7 Australia Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
9 South America
9.1 South America Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2032)
9.2 South America Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2032)
9.3 South America Circulating Tumor Cell(CTC)Detection Market Size by Country
9.3.1 South America Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2021-2032)
9.3.2 Brazil Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
9.3.3 Argentina Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country
10.3.1 Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2021-2032)
10.3.2 Turkey Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
10.3.4 UAE Circulating Tumor Cell(CTC)Detection Market Size and Forecast (2021-2032)
11 Market Dynamics
11.1 Circulating Tumor Cell(CTC)Detection Market Drivers
11.2 Circulating Tumor Cell(CTC)Detection Market Restraints
11.3 Circulating Tumor Cell(CTC)Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Circulating Tumor Cell(CTC)Detection Industry Chain
12.2 Circulating Tumor Cell(CTC)Detection Upstream Analysis
12.3 Circulating Tumor Cell(CTC)Detection Midstream Analysis
12.4 Circulating Tumor Cell(CTC)Detection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Global Circulating Tumor Cell(CTC)Detection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Circulating Tumor Cell(CTC)Detection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Circulating Tumor Cell(CTC)Detection Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Circulating Tumor Cell(CTC)Detection Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Rarecyte Company Information, Head Office, and Major Competitors
Table 6. Rarecyte Major Business
Table 7. Rarecyte Circulating Tumor Cell(CTC)Detection Product and Solutions
Table 8. Rarecyte Circulating Tumor Cell(CTC)Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Rarecyte Recent Developments and Future Plans
Table 10. ANGLE plc Company Information, Head Office, and Major Competitors
Table 11. ANGLE plc Major Business
Table 12. ANGLE plc Circulating Tumor Cell(CTC)Detection Product and Solutions
Table 13. ANGLE plc Circulating Tumor Cell(CTC)Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. ANGLE plc Recent Developments and Future Plans
Table 15. Biocept Inc. Company Information, Head Office, and Major Competitors
Table 16. Biocept Inc. Major Business
Table 17. Biocept Inc. Circulating Tumor Cell(CTC)Detection Product and Solutions
Table 18. Biocept Inc. Circulating Tumor Cell(CTC)Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bio-Rad Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 20. Bio-Rad Laboratories Inc. Major Business
Table 21. Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Product and Solutions
Table 22. Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Bio-Rad Laboratories Inc. Recent Developments and Future Plans
Table 24. Fluxion Biosciences Inc. Company Information, Head Office, and Major Competitors
Table 25. Fluxion Biosciences Inc. Major Business
Table 26. Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Product and Solutions
Table 27. Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Fluxion Biosciences Inc. Recent Developments and Future Plans
Table 29. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
Table 30. F. Hoffmann-La Roche AG Major Business
Table 31. F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Product and Solutions
Table 32. F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. F. Hoffmann-La Roche AG Recent Developments and Future Plans
Table 34. Sysmex Europe SE Company Information, Head Office, and Major Competitors
Table 35. Sysmex Europe SE Major Business
Table 36. Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Product and Solutions
Table 37. Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Sysmex Europe SE Recent Developments and Future Plans
Table 39. Qiagen Company Information, Head Office, and Major Competitors
Table 40. Qiagen Major Business
Table 41. Qiagen Circulating Tumor Cell(CTC)Detection Product and Solutions
Table 42. Qiagen Circulating Tumor Cell(CTC)Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Qiagen Recent Developments and Future Plans
Table 44. Global Circulating Tumor Cell(CTC)Detection Revenue (USD Million) by Players (2021-2026)
Table 45. Global Circulating Tumor Cell(CTC)Detection Revenue Share by Players (2021-2026)
Table 46. Breakdown of Circulating Tumor Cell(CTC)Detection by Company Type (Tier 1, Tier 2, and Tier 3)
Table 47. Market Position of Players in Circulating Tumor Cell(CTC)Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 48. Head Office of Key Circulating Tumor Cell(CTC)Detection Players
Table 49. Circulating Tumor Cell(CTC)Detection Market: Company Product Type Footprint
Table 50. Circulating Tumor Cell(CTC)Detection Market: Company Product Application Footprint
Table 51. Circulating Tumor Cell(CTC)Detection New Market Entrants and Barriers to Market Entry
Table 52. Circulating Tumor Cell(CTC)Detection Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global Circulating Tumor Cell(CTC)Detection Consumption Value (USD Million) by Type (2021-2026)
Table 54. Global Circulating Tumor Cell(CTC)Detection Consumption Value Share by Type (2021-2026)
Table 55. Global Circulating Tumor Cell(CTC)Detection Consumption Value Forecast by Type (2027-2032)
Table 56. Global Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2026)
Table 57. Global Circulating Tumor Cell(CTC)Detection Consumption Value Forecast by Application (2027-2032)
Table 58. North America Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 59. North America Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 60. North America Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 61. North America Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 62. North America Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 63. North America Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 64. Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 65. Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 66. Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 67. Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 68. Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 69. Europe Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 70. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 72. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 74. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 77. South America Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 78. South America Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 79. South America Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 80. South America Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 81. South America Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 87. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 88. Global Key Players of Circulating Tumor Cell(CTC)Detection Upstream (Raw Materials)
Table 89. Global Circulating Tumor Cell(CTC)Detection Typical Customers
List of Figures
Figure 1. Circulating Tumor Cell(CTC)Detection Picture
Figure 2. Global Circulating Tumor Cell(CTC)Detection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Type in 2025
Figure 4. Epithelial Cell Phenotype
Figure 5. Mesenchymal Cell Phenotype
Figure 6. Mixed Epithelial-Mesenchymal Phenotype
Figure 7. Global Circulating Tumor Cell(CTC)Detection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Application in 2025
Figure 9. Cancer Diagnosis Picture
Figure 10. Tumor Dynamic Assessment Picture
Figure 11. Tumor Recurrence Monitoring Picture
Figure 12. Global Circulating Tumor Cell(CTC)Detection Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global Circulating Tumor Cell(CTC)Detection Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global Market Circulating Tumor Cell(CTC)Detection Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 15. Global Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Region (2021-2032)
Figure 16. Global Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Region in 2025
Figure 17. North America Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 18. Europe Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 19. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 20. South America Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 21. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Circulating Tumor Cell(CTC)Detection Revenue Share by Players in 2025
Figure 24. Circulating Tumor Cell(CTC)Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 25. Market Share of Circulating Tumor Cell(CTC)Detection by Player Revenue in 2025
Figure 26. Top 3 Circulating Tumor Cell(CTC)Detection Players Market Share in 2025
Figure 27. Top 6 Circulating Tumor Cell(CTC)Detection Players Market Share in 2025
Figure 28. Global Circulating Tumor Cell(CTC)Detection Consumption Value Share by Type (2021-2026)
Figure 29. Global Circulating Tumor Cell(CTC)Detection Market Share Forecast by Type (2027-2032)
Figure 30. Global Circulating Tumor Cell(CTC)Detection Consumption Value Share by Application (2021-2026)
Figure 31. Global Circulating Tumor Cell(CTC)Detection Market Share Forecast by Application (2027-2032)
Figure 32. North America Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Type (2021-2032)
Figure 33. North America Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Application (2021-2032)
Figure 34. North America Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Country (2021-2032)
Figure 35. United States Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 36. Canada Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 37. Mexico Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 38. Europe Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Type (2021-2032)
Figure 39. Europe Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Application (2021-2032)
Figure 40. Europe Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Country (2021-2032)
Figure 41. Germany Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 42. France Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 43. United Kingdom Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 44. Russia Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 45. Italy Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 46. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Type (2021-2032)
Figure 47. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Application (2021-2032)
Figure 48. Asia-Pacific Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Region (2021-2032)
Figure 49. China Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 50. Japan Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 51. South Korea Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 52. India Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 53. Southeast Asia Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 54. Australia Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 55. South America Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Type (2021-2032)
Figure 56. South America Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Application (2021-2032)
Figure 57. South America Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Country (2021-2032)
Figure 58. Brazil Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 59. Argentina Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 60. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Type (2021-2032)
Figure 61. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Application (2021-2032)
Figure 62. Middle East & Africa Circulating Tumor Cell(CTC)Detection Consumption Value Market Share by Country (2021-2032)
Figure 63. Turkey Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 64. Saudi Arabia Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 65. UAE Circulating Tumor Cell(CTC)Detection Consumption Value (2021-2032) & (USD Million)
Figure 66. Circulating Tumor Cell(CTC)Detection Market Drivers
Figure 67. Circulating Tumor Cell(CTC)Detection Market Restraints
Figure 68. Circulating Tumor Cell(CTC)Detection Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Circulating Tumor Cell(CTC)Detection Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
提及公司
同分類最新報告（資通訊）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Global Info Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們